Amylyx Pharmaceuticals, Inc. Intrinsic Value

AMLX

Amylyx Pharmaceuticals fair value

None of the figures this calculator works from (earnings, free cash flow, revenue, book value, dividends) is positive for Amylyx Pharmaceuticals today, so there is nothing to project yet.

SourceFair value computed from the 10-Q filed 27 Jul 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 7 Aug 2026. How this is calculated.

Price from market data, last close as of 4 Nov 2026. Fiscal year ends Dec.

Peers

Pharmaceutical Preparations · Pick stocks to compare with AMLX

CompareIntrinsic value

JANXJanux Therapeutics Inc.

$18.18+2.02%40

PBYIPuma Biotechnology Inc.

$10.69+4.60%68

ZLABZai Lab Ltd

$22.80+3.83%40

ACRSAclaris Therapeutics, Inc.

$3.68-1.60%10

IRWDIronwood Pharmaceuticals Inc.

$3.77+7.71%52

XENEXenon Pharmaceuticals Inc.

$39.19+2.50%10

ORGOOrganogenesis Holdings Inc.

$0.87+4.19%50

AUPHAurinia Pharmaceuticals Inc.

$17.11+3.32%58

Held by ETFs

AMLX is in 45 US ETFs. The largest of them, with AMLX's weight in each:

Spot a number that looks wrong? Check it in AMLX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing AMLX

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.